Nara, Japan

Yoshihiro Sumita

This inventor holds 2 USPTO granted patents. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 1998-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiro Sumita. Retrieved from https://idiyas.com/inventor/yoshihiro-sumita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yoshihiro Sumita

Introduction

Yoshihiro Sumita is a notable inventor based in Nara-ken, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds. With a total of 2 patents to his name, his work has had a considerable impact on medical science.

Latest Patents

Sumita's latest patents include innovative advancements in the pharmaceutical industry. His first patent focuses on &bgr;-lactam compounds and the process for producing the same. The second patent pertains to Carbapenem compounds and the process for producing the same. These inventions are crucial for developing effective antibiotics and other therapeutic agents.

Career Highlights

Yoshihiro Sumita is currently employed at Sumitomo Pharmaceuticals Company Limited, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in advancing the company's portfolio of innovative drugs.

Collaborations

Throughout his career, Sumita has collaborated with talented individuals such as Makoto Sunagawa and Hiroshi Yamaga. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Yoshihiro Sumita's contributions to the field of pharmaceuticals through his patents and collaborations highlight his importance as an inventor. His work continues to influence the industry and improve healthcare outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…